Latest news
Loading news…
Oryzon Genomics SA
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Barcelona, Catalonia, Spain Founded 2000 11-50 employees For Profit
Oryzon Genomics is a biopharmaceutical company developing epigenetics-based therapeutics for patients with cancer and CNS disorders.
Oryzon Genomics SA on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Total Funding
$259.2M
Funding Rounds
26
Last Funding
Acquisitions
1
Monthly Visits
Contacts
20
Ticker
ORY
BME - Madrid Stock Exchange
Patents
86
3 trademarks
About Oryzon Genomics SA
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- ORY
- Exchange
- BME - Madrid Stock Exchange
- IPO date
- Dec 14, 2015
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- Active products
- 12
- Patents granted
- 86
- Trademarks
- 3
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $201.82K
Company Info
- Founded
- 2000
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- Sub-organizations
- 1
- News articles
- 95
- HQ
- Barcelona, Catalonia, Spain
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- Dec 14, 2015
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- 7.7
- Trend (90d)
- 7.7
- Last leadership hire
- Feb 12, 2026
Oryzon Genomics SA Funding Rounds
26 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–5 of 26Show
Page 1 / 6
Oryzon Genomics SA Acquisitions
1 results
| Acquiree Name | Acquirer Name | Acquiree Industries | Acquiree Hq Country | ||
|---|---|---|---|---|---|
| Crystax Pharmaceuticals | — | 2009-03-20 | Oryzon Genomics SA | Biotechnology | Spain |
1–1 of 1Show
Page 1 / 1
Oryzon Genomics SA Key People
Founder and CEO
Global Chief Medical Officer
Director of Business Development
Chief Intellectual Property Officer
Chief Financial Officer
Senior Advisor for Regulatory Affairs
Founder and Shareholder
Chief Scientific Officer
20
professional contacts at Oryzon Genomics SA
Contact execs at Oryzon Genomics SA →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Oryzon Genomics SA
Loading news…
FAQs about Oryzon Genomics SA
People who checked this page also checked these
Browse the full Acquirezy directory.